Results 191 to 200 of about 30,223 (276)

Efficient Modulation of Exon Skipping via Antisense Circular RNAs. [PDF]

open access: yesResearch (Wash D C), 2023
Ren S   +8 more
europepmc   +1 more source

Volitional exercise elicits physiological and molecular improvements in the severe D2.mdx mouse model of Duchenne muscular dystrophy

open access: yesThe Journal of Physiology, Volume 604, Issue 2, Page 849-867, 15 January 2026.
Abstract figure legend This study investigated the effects of volitional exercise on muscle health in the more severe D2.mdx model of Duchenne muscular dystrophy (DMD). We showed that 8–10 weeks of a relatively high volume of voluntary wheel running (VWR) in D2.mdx animals augmented select muscle mass and normalized ex vivo muscle force compared to ...
Stephanie R. Mattina   +7 more
wiley   +1 more source

PPP1R12A Mutation Presenting With Congenital Jejunal Atresia and Short Stature: A Pediatric Endocrinology Case Report

open access: yesCase Reports in Pediatrics, Volume 2026, Issue 1, 2026.
We report an 11‐year‐old Hispanic male with a PPP1R12A gene de novo heterozygous likely pathogenic mutation, p. (Gln13Arg) (CAG>CGG), c.38 A > G in Exon 1 (NM_002480.2), detected on whole‐exome trio sequencing during his short‐stature evaluation.
Rosita Saul   +5 more
wiley   +1 more source

Dual CRISPR-Cas3 system for inducing multi-exon skipping in DMD patient-derived iPSCs. [PDF]

open access: yesStem Cell Reports, 2023
Kita Y   +10 more
europepmc   +1 more source

MET exon 14 skipping mutations and gene amplification in a Taiwanese lung cancer population

open access: gold, 2019
Jrhau Lung   +12 more
openalex   +2 more sources

Supplemental Figure S3 from Co-occurring Alterations in the RAS–MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer

open access: gold, 2023
Julia Rotow   +24 more
openalex   +1 more source

RNA‐Seq of Cultured Peripheral Blood Lymphocytes Improves Identification of Cryptic Splicing Defects in Rare Disease Diagnostics

open access: yesHuman Mutation, Volume 2026, Issue 1, 2026.
Accurate identification of the genetic determinants of rare diseases is essential for effective recurrence‐risk management and informed reproductive decision‐making. Although whole‐exome sequencing (WES) and whole‐genome sequencing (WGS) have significantly improved diagnostic capabilities, a subset of affected families still receives no definitive ...
Jinlin Ren   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy